²»Á¼Ñо¿Ëù

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.

²»Á¼Ñо¿Ëù Chief Operating Officer Kathryn Corzo featured in Endpoints News.

²»Á¼Ñо¿Ëù appoints accomplished biotechnology executive and drug developer Kathryn Corzo as Chief Operating Officer.

The pledge is part of our mission to code cells for novel cures and to be a purpose led company.

This feature covers the latest fundraise and appointments to the board.

Funding raised to accelerate and expand cell therapy pipeline.

²»Á¼Ñо¿Ëù adds $100M+ to its coffers and some impressive names to its board of directors.

Three world leaders in science and entrepreneurship appointed to ²»Á¼Ñо¿Ëù's Board of Directors.